Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria, Encouse B. Golden, Silvia C. Formenti
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1325-1325
Closed Access | Times Cited: 650

Showing 1-25 of 650 citing articles:

Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin, Ralph T. H. Leijenaar, Timo M. Deist, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 749-762
Open Access | Times Cited: 4237
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1436
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 7, pp. 895-903
Open Access | Times Cited: 977
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul, Zvi G. Fridlender
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 601-620
Closed Access | Times Cited: 752
Breast Cancer Immunotherapy: Facts and Hopes
Leisha A. Emens
Clinical Cancer Research (2017) Vol. 24, Iss. 3, pp. 511-520
Open Access | Times Cited: 674
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Charlene M. Fares, Eliezer M. Van Allen, Charles G. Drake, et al.
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. 147-164
Closed Access | Times Cited: 558
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 522
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, et al.
European Journal of Cancer (2017) Vol. 81, pp. 116-129
Closed Access | Times Cited: 506
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal Patel, Andy J. Minn
Immunity (2018) Vol. 48, Iss. 3, pp. 417-433
Open Access | Times Cited: 492
Recent Developments in Radiotherapy
Deborah E. Citrin
New England Journal of Medicine (2017) Vol. 377, Iss. 11, pp. 1065-1075
Closed Access | Times Cited: 392
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride, Eric J. Sherman, C. Jillian Tsai, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 1, pp. 30-37
Open Access | Times Cited: 328
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li, Changshun Shao, Yufang Shi, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 321
Current Landscape of Immunotherapy in Breast Cancer
Sylvia Adams, Margaret E. Gatti‐Mays, Kevin Kalinsky, et al.
JAMA Oncology (2019) Vol. 5, Iss. 8, pp. 1205-1205
Open Access | Times Cited: 313
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, et al.
International Journal of Radiation Oncology*Biology*Physics (2017) Vol. 100, Iss. 4, pp. 916-925
Closed Access | Times Cited: 293
Improving radiotherapy in cancer treatment: Promises and challenges
Helen H.W. Chen, Macus Tien Kuo
Oncotarget (2017) Vol. 8, Iss. 37, pp. 62742-62758
Open Access | Times Cited: 281
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L. Whiteside, Sandra Demaria, María E. Rodríguez-Ruiz, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 8, pp. 1845-1855
Open Access | Times Cited: 280
Time to abandon single-site irradiation for inducing abscopal effects
Eric D. Brooks, Joe Y. Chang
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 123-135
Closed Access | Times Cited: 276
Clinical development of new drug–radiotherapy combinations
Ricky A. Sharma, Ruth Plummer, Julie Stock, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 10, pp. 627-642
Open Access | Times Cited: 273
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 563-569
Open Access | Times Cited: 267
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
Nasser K. Altorki, Timothy E. McGraw, Alain Borczuk, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. 824-835
Closed Access | Times Cited: 262
Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses
Qian Chen, Muchao Chen, Zhuang Liu
Chemical Society Reviews (2019) Vol. 48, Iss. 22, pp. 5506-5526
Closed Access | Times Cited: 254
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn, E. John Wherry
Cell (2016) Vol. 165, Iss. 2, pp. 272-275
Open Access | Times Cited: 251
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Saray Garasa, et al.
Cancer Research (2016) Vol. 76, Iss. 20, pp. 5994-6005
Open Access | Times Cited: 216
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
James W. Welsh, Hari Menon, Dawei Chen, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001001-e001001
Open Access | Times Cited: 212
Biological effects of radiation on cancer cells
Jinsong Wang, Haijuan Wang, Haili Qian
Military Medical Research (2018) Vol. 5, Iss. 1
Open Access | Times Cited: 205
Page 1 - Next Page

Scroll to top